Discontinuing Chronic Medications Suggested for Deprescribing in Routine Clinical Practice: Nationwide Evidence From Routinely Collected Data in Swedish Older Adults
Basic & Clinical Pharmacology & Toxicology · 2025
DOI: 10.1111/bcpt.70093 ↗At a glance
Journal article in Basic & Clinical Pharmacology & Toxicology, 2025. Written by Karl-Hermann Sielinou Kamgang and 4 co-authors. Institution: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Major MEDLINE topics: Deprescriptions. Cited 2 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Swedish Research Council for Health, Working Life and Welfare, Forskningsrådet om Hälsa, Arbetsliv och Välfärd.
Topics: Gerontologische Pflege
Abstract (original language)
Background
National estimates of drug discontinuation for deprescribing targets in older adults are limited, partly due to challenges distinguishing planned deprescribing from poor adherence. Focusing on individuals with multidose dispensing (MDD), characterized by high adherence by design, may yield realistic discontinuation rates.
Aims
To estimate the rates of discontinuation for chronically used drugs targeted for deprescribing among older adults, and to describe reinitiation among users of MDD and standard dispensing (non‐MDD).
Methods
In this nationwide cohort study, Swedish adults aged ≥ 75 were identified from national registers. At baseline (1 January 2021), chronic users of seven drug classes were defined. We estimated the 12‐month cumulative incidence of discontinuation (defined as no new dispensing during the treatment episode of the prior dispensing plus a 180‐day grace period) and the proportion of patients restarting therapy within 180 days after discontinuation.
Results
We identified 162 518 chronic users: benzodiazepines ( n = 69 511), PPIs ( n = 43 973), antidepressants ( n = 41 577), statins ( n = 36 085), cholinesterase inhibitors ( n = 6408), bisphosphonates ( n = 5801) and antipsychotics ( n = 4380). Discontinuation rates were low (8.3–51.5 per 1000 person‐years), and non‐MDD users had higher discontinuation and reinitiation rates across all drugs.
Conclusion
Discontinuation among Swedish older adults is infrequent. Irregular dispensing is likely misclassified as deprescribing, and MDD users may better reflect true discontinuation in routinely collected data.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense M, Denmark.
- Hospital Pharmacy Funen, Odense University Hospital, Odense C, Denmark.
- Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
ORCID profiles: Karl-Hermann Sielinou Kamgang, Carina Lundby, Jonas W Wastesson
Funding
- Swedish Research Council for Health, Working Life and Welfare
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd
Cite
APA
Kamgang, K. S., Lundby, C., Szilcz, M., Johnell, K., & Wastesson, J. W. (2025). Discontinuing Chronic Medications Suggested for Deprescribing in Routine Clinical Practice: Nationwide Evidence From Routinely Collected Data in Swedish Older Adults. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70093
Vancouver
Kamgang KS, Lundby C, Szilcz M, Johnell K, Wastesson JW. Discontinuing Chronic Medications Suggested for Deprescribing in Routine Clinical Practice: Nationwide Evidence From Routinely Collected Data in Swedish Older Adults. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70093
BibTeX
@article{Kamgang2025,
author = {Kamgang, Karl-Hermann Sielinou and Lundby, Carina and Szilcz, Máté and Johnell, Kristina and Wastesson, Jonas W},
title = {Discontinuing Chronic Medications Suggested for Deprescribing in Routine Clinical Practice: Nationwide Evidence From Routinely Collected Data in Swedish Older Adults},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
doi = {10.1111/bcpt.70093}
}
EUVIMED